JGC Holdings is pursuing biomanufacturing using microorganisms, with the aim of diversifying the risks associated with dependence on oil. It has established a Bioprocess Research Institute in Kobe and is advancing technology development for scale-up, with the goal of achieving social implementation in 2030.
JGC Holdings is focusing on biomanufacturing, a field that uses microorganisms to produce useful products. According to an article based on reporting from the research site, the aim is to diversify the risks associated with dependence on oil.
The Bioprocess Research Institute established in Kobe serves as the central base. The company aims to achieve social implementation by 2030 and is advancing technology development for scale-up.
Future attention will focus on developments at the research and development site and the specific technical challenges involved in scale-up. The article features current initiatives and their future progress.